TWI476011B - Biological affinity material and method for producing the same - Google Patents

Biological affinity material and method for producing the same Download PDF

Info

Publication number
TWI476011B
TWI476011B TW097140274A TW97140274A TWI476011B TW I476011 B TWI476011 B TW I476011B TW 097140274 A TW097140274 A TW 097140274A TW 97140274 A TW97140274 A TW 97140274A TW I476011 B TWI476011 B TW I476011B
Authority
TW
Taiwan
Prior art keywords
collagen
hydroxyapatite
sodium
weight
composite
Prior art date
Application number
TW097140274A
Other languages
English (en)
Chinese (zh)
Other versions
TW200927154A (en
Inventor
岡田芳明
Original Assignee
艾爾畢斯股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 艾爾畢斯股份有限公司 filed Critical 艾爾畢斯股份有限公司
Publication of TW200927154A publication Critical patent/TW200927154A/zh
Application granted granted Critical
Publication of TWI476011B publication Critical patent/TWI476011B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW097140274A 2007-10-26 2008-10-21 Biological affinity material and method for producing the same TWI476011B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007278908A JP4369969B2 (ja) 2007-10-26 2007-10-26 生体適合性材料並びにその製造方法

Publications (2)

Publication Number Publication Date
TW200927154A TW200927154A (en) 2009-07-01
TWI476011B true TWI476011B (zh) 2015-03-11

Family

ID=40583149

Family Applications (1)

Application Number Title Priority Date Filing Date
TW097140274A TWI476011B (zh) 2007-10-26 2008-10-21 Biological affinity material and method for producing the same

Country Status (5)

Country Link
US (2) US8241671B2 (cg-RX-API-DMAC7.html)
JP (1) JP4369969B2 (cg-RX-API-DMAC7.html)
KR (1) KR101299342B1 (cg-RX-API-DMAC7.html)
CN (1) CN101417124B (cg-RX-API-DMAC7.html)
TW (1) TWI476011B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090036656A1 (en) * 2007-07-31 2009-02-05 Body Organ Biomedical Corp. Method for preparing a biomaterial
JP5336722B2 (ja) * 2007-10-26 2013-11-06 株式会社アールビーエス リン、カルシウム、マグネシウム、ナトリウム等のミネラル成分を含むハイドロキシアパタイトの製造方法並びにリン、カルシウム、マグネシウム、ナトリウム等のミネラル成分を含むハイドロキシアパタイト。
JP4369969B2 (ja) * 2007-10-26 2009-11-25 株式会社アールビーエス 生体適合性材料並びにその製造方法
JP5248848B2 (ja) * 2007-12-11 2013-07-31 山八歯材工業株式会社 インプラントの製造方法及び人工歯根の製造方法
CN101480503B (zh) * 2008-01-09 2012-10-17 柏登生医股份有限公司 配制生物材料的方法
JP5350921B2 (ja) * 2009-07-13 2013-11-27 株式会社アールビーエス 生体適合性材料の製造方法並びに生体適合性材料並びに食品
US20140066379A1 (en) * 2012-08-30 2014-03-06 Body Organ Biomedical Corp. Recombinant vector, transgenic fish egg using the same and biomaterial using the same
KR101433242B1 (ko) * 2012-11-16 2014-08-25 경북대학교 산학협력단 정복 시술 로봇 및 그의 구동 제어 방법
US10383976B1 (en) 2018-10-08 2019-08-20 King Saud University Method of fabricating nanostructures from fish waste
WO2025068767A1 (en) * 2023-09-29 2025-04-03 Salmoss Spa Aquatic-derived hydroxyapatite biomaterials and related methods
CN121775215B (zh) * 2026-03-03 2026-06-30 杭州芊浔生物科技有限公司 非交联鱼鳞源可注射凝胶及其制备方法和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1628540A (zh) * 2003-12-16 2005-06-22 威海市宇王水产有限公司 鱼鳞胶原蛋白的生产方法
CN1775950A (zh) * 2005-10-19 2006-05-24 由守谊 一种鱼鳞胶原蛋白生产工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3626414C2 (de) * 1986-08-05 1994-11-10 Robapharm Ag Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
JPH05155900A (ja) 1991-09-30 1993-06-22 Nippon Kasei Chem Co Ltd 高純度の酸不溶性魚鱗コラーゲンおよびその製造法
EP0842670A1 (en) * 1996-11-13 1998-05-20 Katsunari Nishihara Biomedical materials
JPH10216214A (ja) * 1996-11-13 1998-08-18 Katsunari Nishihara 医用材料
JP2001211895A (ja) 2000-02-04 2001-08-07 Kenji Kida 生理活性ペプチドの製造法
JP4010484B2 (ja) 2002-02-18 2007-11-21 株式会社成和化成 魚鱗由来加水分解コラーゲンの製造方法
JP2003327599A (ja) 2002-03-08 2003-11-19 Nitta Gelatin Inc 魚由来コラーゲン、その製造方法およびその用途
KR100699324B1 (ko) * 2003-02-19 2007-03-23 나카가와모모키 어린단백질 가수분해물의 제조방법
JP2006067809A (ja) * 2004-08-31 2006-03-16 Shida Kanzume Kk 炎症性サイトカインの製造方法
JP5341299B2 (ja) * 2005-12-28 2013-11-13 株式会社アールビーエス コラーゲンの製造方法及び低分子コラーゲン
JP4369969B2 (ja) * 2007-10-26 2009-11-25 株式会社アールビーエス 生体適合性材料並びにその製造方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1628540A (zh) * 2003-12-16 2005-06-22 威海市宇王水产有限公司 鱼鳞胶原蛋白的生产方法
CN1775950A (zh) * 2005-10-19 2006-05-24 由守谊 一种鱼鳞胶原蛋白生产工艺

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Nippon Shokuhin Kagaku Kagaku Kaishi Vol. 50, No. 2, 67~71(2003) Journal of Biomedical Research Part A, 114-127, 2006-06-08 NOVEL Hap/COL COMPOSITE BIOMATERIAL, 445-453, 25 August 2000 *

Also Published As

Publication number Publication date
US8241671B2 (en) 2012-08-14
KR101299342B1 (ko) 2013-08-26
JP2009107938A (ja) 2009-05-21
US20120251626A1 (en) 2012-10-04
CN101417124A (zh) 2009-04-29
CN101417124B (zh) 2013-03-13
KR20090042742A (ko) 2009-04-30
TW200927154A (en) 2009-07-01
US8409622B2 (en) 2013-04-02
JP4369969B2 (ja) 2009-11-25
US20090110748A1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
JP4369969B2 (ja) 生体適合性材料並びにその製造方法
JP2009107938A5 (cg-RX-API-DMAC7.html)
Wiens et al. The role of biosilica in the osteoprotegerin/RANKL ratio in human osteoblast-like cells
Yokel et al. Aluminum bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from water
US20120040908A1 (en) Fracture repair promoter
Liu et al. The effectiveness of polypeptides from phosvitin and eggshell membrane in enhancing the bioavailability of eggshell powder calcium and its accumulation in bones
CN115669839B (zh) 一种牛骨胶原肽-钙螯合固体饮料及其制备方法
Słota et al. Ceramic-polymer coatings on Ti-6Al-4V alloy modified with L-cysteine in biomedical applications
Zhang et al. Preparation and characterization of a novel walnut peptide–calcium chelate and its role in promoting calcium absorption in calcium-deficient mice
Yang et al. Prevention of osteoporosis in ovariectomized mice with calcium yak caseinate
TWI586362B (zh) 新穎蛋白質素材
JPS6344527A (ja) 軟骨細胞および骨芽細胞を刺激する組成物、オセインヒドロキシアパタイトコンパウンド、その製法、および前記組成物を含む製剤生成物
Adji et al. Sustainable synthesis of hydroxyapatite from poultry waste for veterinary applications: A calcination approach
CN101861332B (zh) 用于促进成骨细胞分化和抑制破骨细胞分化的食品原材料
Sikorska et al. Can silver nanoparticles affect the mineral content, structure and mechanical properties of chicken embryo bones?
JP5350921B2 (ja) 生体適合性材料の製造方法並びに生体適合性材料並びに食品
JP5336722B2 (ja) リン、カルシウム、マグネシウム、ナトリウム等のミネラル成分を含むハイドロキシアパタイトの製造方法並びにリン、カルシウム、マグネシウム、ナトリウム等のミネラル成分を含むハイドロキシアパタイト。
RU2270586C2 (ru) Пищевая кальцийсодержащая добавка и функциональный пищевой продукт ее содержащий
Yang et al. Potential antiosteoporosis effect of biodegradable magnesium implanted in STZ‐induced diabetic rats
ELGendi et al. Characterization and Potential of Enhancing Bone Regeneration Using Raw Cuttlebone Aragonite Nanoparticles: In Vitro and In Vivo Studies.
CN113599397B (zh) 一种软骨提取物及其制备方法和应用
JP2009242422A5 (cg-RX-API-DMAC7.html)
Prentice The effects of silicon on skeletal integrity in poultry
JP3379198B2 (ja) ミネラル吸収促進飲食品
AU2021105821A4 (en) An invention of calcium supplement based on eggshell powder and its preparation methods

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees